Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carozzi

Showing results (301-310 of 413) with videos related to

Pageof 42
Sort By:
International Journal of Cancer|January 18, 2018
Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programsKate Cuschieri, Guglielmo Ronco, Attila Lorincz, et al.
Journal of Clinical Microbiology|June 8, 2006
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samplesMaria T Sandri, Paola Lentati, Elvira Benini, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 13, 2014
Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalenceFrancesca Carozzi, Laura De Marco, Anna Gillio-Tos, et al.
Antioxidants (Basel, Switzerland)|July 11, 2020
Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral NeurotoxicityAnnalisa Canta, Alessia Chiorazzi, Eleonora Pozzi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2008
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CTAndrea Lopes Pegna, Giulia Picozzi, Mario Mascalchi, et al.
International Journal of Cancer|April 8, 2017
Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker studyFrancesca Maria Carozzi, Simonetta Bisanzi, Laura Carrozzi, et al.
Diagnostic Cytopathology|August 19, 2007
Interlaboratory reproducibility of liquid-based equivocal cervical cytology within a randomized controlled trial frameworkM Confortini, A Bondi, M P Cariaggi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 11, 2014
The age distribution of type-specific high-risk human papillomavirus incidence in two population-based screening trialsNienke J Veldhuijzen, Johannes Berkhof, Anna Gillio-Tos, et al.
BMC Infectious Diseases|January 17, 2018
Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, ItalyFrancesca Carozzi, Donella Puliti, Cristina Ocello, et al.
Infectious Agents and Cancer|November 1, 2012
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studiesPaolo Giorgi Rossi, Mario Sideri, Francesca Maria Carozzi, et al.
Pageof 42

Showing results (301-310 of 413) with videos related to

Sort By:
Pageof 42
International Journal of Cancer|January 18, 2018
Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programsKate Cuschieri, Guglielmo Ronco, Attila Lorincz, et al.
Journal of Clinical Microbiology|June 8, 2006
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samplesMaria T Sandri, Paola Lentati, Elvira Benini, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 13, 2014
Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalenceFrancesca Carozzi, Laura De Marco, Anna Gillio-Tos, et al.
Antioxidants (Basel, Switzerland)|July 11, 2020
Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral NeurotoxicityAnnalisa Canta, Alessia Chiorazzi, Eleonora Pozzi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2008
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CTAndrea Lopes Pegna, Giulia Picozzi, Mario Mascalchi, et al.
International Journal of Cancer|April 8, 2017
Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker studyFrancesca Maria Carozzi, Simonetta Bisanzi, Laura Carrozzi, et al.
Diagnostic Cytopathology|August 19, 2007
Interlaboratory reproducibility of liquid-based equivocal cervical cytology within a randomized controlled trial frameworkM Confortini, A Bondi, M P Cariaggi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 11, 2014
The age distribution of type-specific high-risk human papillomavirus incidence in two population-based screening trialsNienke J Veldhuijzen, Johannes Berkhof, Anna Gillio-Tos, et al.
BMC Infectious Diseases|January 17, 2018
Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, ItalyFrancesca Carozzi, Donella Puliti, Cristina Ocello, et al.
Infectious Agents and Cancer|November 1, 2012
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studiesPaolo Giorgi Rossi, Mario Sideri, Francesca Maria Carozzi, et al.
Pageof 42